OOIR: Observatory of International Research

Papers

(The H4-Index of Neurology-Neuroimmunology & Neuroinflammation is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Clinical Presentation, Management, and Diagnostic Performance of 2021 Criteria for Paraneoplastic Neurologic Syndromes in Childhood	157
Natalizumab Treatment Induces Proinflammatory CD4 T Cells Preferentially in the Integrin β7+ Compartment	138
Relapsing and Immune-Responsive Paroxysmal Jaw Clonus With Blepharospasm and Sialorrhea Associated With D2R Autoantibodies	114
Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod	94
Comment: Humoral and T-cell Immunities to SARS-CoV-2 Vaccines: Safety, Efficacy, and Challenges in Autoimmune Neurology	87
Immunohistologic Features of Cerebral Venous Thrombosis Due to Vaccine-Induced Immune Thrombotic Thrombocytopenia	78
A 28-Year-Old Woman With Left-Sided Weakness and Atypical MRI Lesions	76
Pro-Inflammatory Molecules Implicated in Multiple Sclerosis Divert the Development of Human Oligodendrocyte Lineage Cells	74
Antibody-Negative Autoimmune Encephalitis	72
MOG IgG3-Subclass Antibodies in MOG-Associated Disease	72
Elevated ITGAX/CD11c in CSF-Derived Extracellular Vesicles Reflects Disability Progression in Multiple Sclerosis	68
CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis	62
Early-Stage Contactin-Associated Protein-like 2 Limbic Encephalitis	61
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD	59
Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis	59
Should We Measure CSF Complement Levels in Patients With MOGAD?	57
Baicalin Promotes CNS Remyelination via PPARγ Signal Pathway	57
Timing of MOG-IgG Testing Is Key to 2023 MOGAD Diagnostic Criteria	56
Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8 ⁺ Regulatory T Cells	56
TNF-Blockade for Primary Stroke Prevention in Adenosine Deaminase 2 Deficiency	55
Synaptic Protein Loss in Extracellular Vesicles Reflects Brain and Retinal Atrophy in People With Multiple Sclerosis	54
Peripheral HLA-DR ^hi CD141 ⁺ Classical Monocytes Predict Relapse Risk and Worsening in Multiple Sclerosis	52
CXCL10/IgG1 Axis in Multiple Sclerosis as a Potential Predictive Biomarker of Disease Activity	52
Cell-Free DNA Derived From Neutrophils Triggers Type 1 Interferon Signature in Neuromyelitis Optica Spectrum Disorder	52
Plasma N -Glycan Profiling Enhances Diagnostic Precision in Multiple Sclerosis, AQP4-Ab NMOSD, and MOGAD	51

Acute Paresthesia and Ataxia in a Child	51
Toward Precision Phenotyping of Multiple Sclerosis	50
Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection	49
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis	49
Relapsing-Remitting Immunotherapy Responsive Small-Fiber Neuropathy	48
Peripheral Immune Profiles Predict ALS Progression in an Age- and Sex-Dependent Manner	48
Treatment With Erythropoietin for Patients With Optic Neuritis	47
Neuropsychological Testing in Autoimmune Encephalitis: A Scoping Review	47
Retinal Optical Coherence Tomography in Neuromyelitis Optica	47
Proteomics Analysis Moves the Needle by Generating Clinical Diagnostic Markers	47
Novel Cell-Based Assay for Alpha-3 Nicotinic Receptor Antibodies Detects Antibodies Exclusively in Autoimmune Autonomic Ganglionopathy	47
Immunotherapy-Responsive Neuropathic Pain and Allodynia in a Patient With Glycine Receptor Autoantibodies	46
Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG–Associated Experimental Autoimmune Encephalomyelitis	46
Trigeminal Nerve Involvement in Bulbar-Onset Anti-IgLON5 Disease	46
Clinical Features of Children With MOG-IgG Who Fulfill Criteria of Multiple Sclerosis and Overlapping Disorders	45
Applying the Supporting Features for MOGAD Diagnosis to Patients With Multiple Sclerosis	42
The Role of Complement Activation in IgM M-Protein–Associated Neuropathies	41